CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 41 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $0 | -100.0% | 199 | -95.9% | 0.00% | – |
Q3 2019 | $2,000 | -80.0% | 4,900 | -87.8% | 0.00% | – |
Q2 2019 | $10,000 | -88.6% | 40,134 | -50.9% | 0.00% | – |
Q1 2019 | $88,000 | +76.0% | 81,707 | +181.1% | 0.00% | – |
Q4 2018 | $50,000 | -66.9% | 29,072 | +11.0% | 0.00% | – |
Q3 2018 | $151,000 | +29.1% | 26,183 | -4.1% | 0.00% | – |
Q2 2018 | $117,000 | -64.1% | 27,306 | -50.9% | 0.00% | – |
Q1 2018 | $326,000 | +107.6% | 55,600 | +63.4% | 0.00% | – |
Q4 2017 | $157,000 | +49.5% | 34,036 | +77.4% | 0.00% | – |
Q3 2017 | $105,000 | +3400.0% | 19,188 | +3098.0% | 0.00% | – |
Q2 2017 | $3,000 | -87.5% | 600 | -85.7% | 0.00% | – |
Q1 2017 | $24,000 | -4.0% | 4,200 | -10.6% | 0.00% | – |
Q4 2016 | $25,000 | – | 4,700 | +2250.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 200 | -84.6% | 0.00% | – |
Q2 2016 | $3,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q1 2016 | $3,000 | +200.0% | 1,300 | +550.0% | 0.00% | – |
Q4 2015 | $1,000 | -66.7% | 200 | -66.7% | 0.00% | – |
Q3 2015 | $3,000 | – | 600 | +59900.0% | 0.00% | – |
Q1 2014 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
Q4 2013 | $8,000 | -65.2% | 1,302 | -43.4% | 0.00% | – |
Q3 2013 | $23,000 | – | 2,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
Quilter Plc | 60,546 | $19,000 | 0.00% |
ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
BlackRock Inc. | 645,611 | $200,000 | 0.00% |
Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |